RecruitingNCT06170021
Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated Radiotherapy
Studying Radiation-induced disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sun Yat-sen University
- Enrollment
- 215 target
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2023 – 2025
Study locations (1)
- Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06170021 on ClinicalTrials.govOther trials for Radiation-induced disorder
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07597083Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer SurvivorsBeni-Suef University
- RECRUITINGPHASE1, PHASE2NCT07269041Immune Tolerance Induction After Liver TransplantationUniversity of California, Los Angeles
- RECRUITINGPHASE2NCT07400328Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT PatientsThe First Affiliated Hospital of Soochow University
- RECRUITINGPHASE2NCT07029178Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and DermatitisShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- RECRUITINGNANCT07510061Title: ICARUS - Psycho-physiological Profiling of Low and High Heat-resilient IndividualsUniversity of Thessaly
- RECRUITINGPHASE2, PHASE3NCT07131319SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLCSecond Affiliated Hospital of Nanchang University
- RECRUITINGPHASE1, PHASE2NCT06714253Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1RiboX Therapeutics Ltd.
- RECRUITINGNCT06443645Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-BCentre Paul Strauss